Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferric Citrate in Anemic CKD Stage 3-5
NCT01736397Phase 2Completed
- Sponsor
- Keryx Biopharmaceuticals, Inc.
- Start
- Nov 2012
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ferric citrate in iron deficiency anemia (IDA), hyperphosphatemia, sponsored by Keryx Biopharmaceuticals, Inc.. Started Nov 2012; status: completed.
02
Drugs
ferric citrate
03
Conditions
iron deficiency anemia (IDA)hyperphosphatemia
Beyond the preview
Go deeper on NCT01736397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01736397.